Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Bursa Sevket Yilmaz Training and Research Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Bursa Sevket Yilmaz Training and Research Hospital as lead sponsor. Synced 15 Nov 2026
4Current trials
0Recruiting now
0Drugs in these trials
1Trial register
At a glance

Bursa Sevket Yilmaz Training and Research Hospital is the lead sponsor of 4 current clinical trials in our Turkey register. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Observational. The most-studied condition is Coronary Artery Bypass Grafting.

ClinicalTrials.gov trials by status

  • Not yet open4100%

Trials by phase

  • Observational4100%
01

Clinical trials sponsored by Bursa Sevket Yilmaz Training and Research Hospital

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Trajectory-Based Phenotyping After Coronary Artery Bypass Surgery
NCT07598682 · ClinicalTrials.gov ↗ · Coronary Artery Bypass Grafting, Postoperative Acute Kidney Injury, Postoperative Complications
Observational Not yet open 2026-05 Turkey
Ultrasound Evaluation of Respiratory Muscles During Mechanical Ventilation Weaning in ICU Patients
NCT07405567 · ClinicalTrials.gov ↗ · Pneumonia, Invasive Mechanical Ventilation, Weaning From Mechanical Ventilation in Care Unit
Observational Not yet open 2026-02 Turkey
Preoperative Fasting Duration and Gastric Residue in Pediatric Upper Gastrointestinal Endoscopy
NCT07614919 · ClinicalTrials.gov ↗ · Gastric Residue, Preoperative Fasting, Upper Gastrointestinal Endoscopy
Observational Not yet open 2026-06 Turkey
Submental Tissue Oxygenation and Arterial Lactate in Major Surgery
NCT07399275 · ClinicalTrials.gov ↗ · Microcirculatory Dysfunction, Tissue Hypoperfusion, Microcirculatory Status
Observational Not yet open 2026-02 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Bursa Sevket Yilmaz Training and Research Hospital trials

15 conditions
Coronary Artery Bypass Grafting1Postoperative Acute Kidney Injury1Postoperative Complications1Risk Stratification1Pneumonia1Invasive Mechanical Ventilation1Weaning From Mechanical Ventilation in Care Unit1Respiratory Muscle Dysfunction1Gastric Residue1Preoperative Fasting1Upper Gastrointestinal Endoscopy1Microcirculatory Dysfunction1Tissue Hypoperfusion1Microcirculatory Status1Microvascular Circulation1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey40

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Coronary Artery Bypass Grafting

SponsorTrials
Second Hospital of Jilin University2

Sponsors with the most current trials registered for this condition.

05

Questions about Bursa Sevket Yilmaz Training and Research Hospital trials

How many clinical trials does Bursa Sevket Yilmaz Training and Research Hospital sponsor?

Bursa Sevket Yilmaz Training and Research Hospital is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are Bursa Sevket Yilmaz Training and Research Hospital trials recruiting?

Not at the moment. None of its 4 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.